Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA

D. Londero, T. Stampalija, D. Bolzicco, E. Castro Silva, M. Candolini, C. Cortivo, C. Dreossi, I. Fantasia, V. Pecile, V. De Angelis

Research output: Contribution to journalArticle

Abstract

Objective: This study aimed to validate non-invasive RHD genotyping of cell-free fetal DNA (cff-DNA) using different DNA extraction methods and of fresh and frozen extracted cff-DNA. Background: Non-invasive RHD genotyping of cff-DNA predicts fetal RhD phenotype, allowing for the rational implementation of antenatal immunoprophylaxis and representing a big step forward in the management of RhD-immunised women. Validation of a diagnostic method is mandatory before its clinical application. Methods: RhD-negative pregnant women were recruited at different gestational ages. The cff-DNA extraction was carried out using manual and automatic methods in order to improve cff-DNA yield and optimise the extraction. Fetal RHD genotyping was performed using a commercial real-time polymerase chain reaction (PCR) kit, and the results were compared with postnatal serological RhD determination on cord blood. Results: Overall, 133 plasma samples were examined for the validation process, and a total of 423 tests were performed. No differences have been observed between the two extraction methods or between fresh or frozen cff-DNA regarding cff-DNA stability and quality parameters. There was 100% concordance between fetal RHD genotyping of cff-DNA and RhD phenotype on cord blood for both extraction methods on both fresh and frozen cff-DNA. Conclusion: Our study shows the reliability of automatic and manual cff-DNA extraction methods and the possibility of freezing extracted cff-DNA when performing RHD genotyping. This result might be relevant for improving laboratory work and organisation through the development of a standardised procedure for fetal RHD genotyping on cff-DNA, laying the foundations for evidence-based use of anti-D Ig prophylaxis in RhD pregnant women.

Original languageEnglish
Pages (from-to)408-414
Number of pages7
JournalTransfusion Medicine
Volume29
Issue number6
DOIs
Publication statusPublished - Dec 1 2019

    Fingerprint

Keywords

  • antenatal immunoprophylaxis
  • automatic extraction technique
  • cell-free fetal DNA
  • fetal RHD genotyping
  • validation

ASJC Scopus subject areas

  • Hematology

Cite this